A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Conditions: Whooping Cough; Diphtheria; Tetanus Interventions: Biological: Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed; Biological: Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed; Biological: Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed ) and Haemophilus influenzae type b conjugate vaccine Sponsors: China National Biotec Group Company Limited; Beijing Institute of Biological Products Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2021 Category: Research Source Type: clinical trials
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Conditions: Whooping Cough; Diphtheria; Tetanus Interventions: Biological: Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed; Biological: Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed; Biological: Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed ) and Haemophilus influenzae type b conjugate vaccine Sponsors: China National Biotec Group Company Limited; Beijing Institute of Biological Products Co Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2021 Category: Research Source Type: clinical trials
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Conditions: Whooping Cough; Diphtheria; Tetanus Interventions: Biological: Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed; Biological: Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed; Biological: Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed ) and Haemophilus influenzae type b conjugate vaccine Sponsors: China National Biotec Group Company Limited; Beijing Institute of Biological Products Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2021 Category: Research Source Type: clinical trials
A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
Condition: Diarrhoea Interventions: Drug: altSonflex Placebo; Biological: altSonflex1-2-3 Dose C; Biological: altSonflex1-2-3 Dose B; Biological: altSonflex1-2-3 Dose A; Biological: GSK's Meningococcal A, C, Y and W-135 conjugate vaccine; Combination Product: GSK's Tetanus toxoid, reduced diphtheria toxoi d and acellular pertussis vaccine; Combination Product: GSK's Poliomyelitis, diphtheria, tetanus and pertussis vaccine; Combination Product: Sanofi Pasteur's Typhoid Vi polysaccharide vaccine; Biological: Serum Institute of India's Measles and rubella vaccine Sponsor: GlaxoSmith...
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials
